King's Foot and Ankle Unit, King's College Hospital NHS Foundation Trust, London, United Kingdom.
Avon Orthopaedic Centre, Southmead Hospital, Bristol, United Kingdom.
Foot Ankle Int. 2023 Feb;44(2):104-117. doi: 10.1177/10711007221146195. Epub 2023 Jan 24.
Recent large studies of third-generation minimally invasive hallux valgus surgery (MIS) have demonstrated significant improvement in clinical and radiologic outcomes. It remains unknown whether these clinical and radiologic outcomes are maintained in the medium to long term. The aim of this study was to investigate the minimum 5-year clinical and radiologic outcomes following third-generation MIS hallux valgus surgery in the hands of a high-volume MIS surgeon.
A retrospective observational single highly experienced MIS surgeon case series of consecutive patients undergoing primary isolated third-generation percutaneous chevron and Akin osteotomies (PECA) for hallux valgus with a minimum 60-month clinical and radiographic follow-up. Primary outcome was radiographic assessment of the hallux valgus angle (HVA) and intermetatarsal angle (IMA) preoperatively, 6 months, and ≥60 months following PECA. Secondary outcomes included the Manchester-Oxford Foot Questionnaire, patient satisfaction, EuroQol-5D visual analog scale and the visual analog scale for pain.
Between 2012 and 2014, 126 consecutive feet underwent isolated third-generation PECA, with complete data available for 78 (61.9%) feet. The median follow-up was 65.0 (IQR 64-69; range 60-88) months. There was a significant improvement in radiographic deformity correction; the median IMA improved from 12.0 degrees (interquartile range [IQR]: 10.8-14.2) to 6.0 degrees (IQR: 4.2-7.3) ( < .001), and the median HVA improved from 27.2 degrees (IQR: 20.6-34.4) to 7.2 degrees (IQR: 3.4-11.6). Median MOXFQ Index score at ≥60-month follow-up was 2.3 (IQR: 0.0-7.8). The radiographic recurrence rate (defined as HVA >15 degrees) was 7.7% at final follow-up. The complication rate was 4.8%.
Radiologic deformity correction for the 78 feet we were able to follow that had third-generation PECA performed by a single highly experienced MIS surgeon was found to be maintained at a mean follow-up of average 66.8 months, with a radiographic recurrence rate of 7.7%. Clinical PROMs and patient satisfaction levels were high and comparable to other third-generation studies with shorter duration of follow-up.
Level IV, retrospective cohort study.
最近的第三代微创足拇外翻手术(MIS)的大型研究表明,临床和影像学结果有显著改善。但尚不清楚这些临床和影像学结果是否能在中长期得到维持。本研究旨在调查一位高容量 MIS 外科医生手中的第三代 MIS 足拇外翻手术后至少 5 年的临床和影像学结果。
回顾性观察性单例高容量 MIS 外科医生连续患者的病例系列,这些患者接受了原发性孤立性第三代经皮楔形和 Akin 截骨术(PECA)治疗足拇外翻,临床和影像学随访至少 60 个月。主要结果是术前、术后 6 个月和 PECA 后≥60 个月时的足拇外翻角(HVA)和跖骨间角(IMA)的影像学评估。次要结果包括曼彻斯特-牛津足部问卷(MOXFQ)、患者满意度、欧洲五维健康量表视觉模拟评分(EQ-5D VAS)和疼痛视觉模拟评分(VAS)。
在 2012 年至 2014 年间,126 只脚接受了单纯的第三代 PECA 治疗,其中 78 只(61.9%)脚的数据完整。中位随访时间为 65.0(IQR 64-69;范围 60-88)个月。影像学畸形矫正有显著改善;IMA 的中位数从 12.0 度(IQR:10.8-14.2)改善至 6.0 度(IQR:4.2-7.3)(<.001),HVA 的中位数从 27.2 度(IQR:20.6-34.4)改善至 7.2 度(IQR:3.4-11.6)。在≥60 个月的随访中,MOXFQ 指数中位数为 2.3(IQR:0.0-7.8)。最终随访时的影像学复发率(定义为 HVA>15 度)为 7.7%。并发症发生率为 4.8%。
对一位高容量 MIS 外科医生进行的第三代 PECA 治疗的 78 只脚进行了平均 66.8 个月的随访,发现影像学畸形矫正得到了维持,影像学复发率为 7.7%。临床 PROMs 和患者满意度水平较高,与其他随访时间较短的第三代研究相当。
IV 级,回顾性队列研究。